अमूर्त

Acute Myeloid Leukemia A Review of Diagnosis and Treatment

Hanuman Borkar*

Acute Myeloid Leukaemia (AML) is a clonal illness defined by the proliferation of immature myeloid cells and bone marrow failure. After induction treatment, cytogenetics and mutation testing remain important prognostic tools. Despite significant progress in the field, AML treatment remains a challenge, despite novel therapeutic targets and a better understanding of the biology. The majority of patients eventually relapse and die. The illness for individuals with intermediate disease, allogenic transplantation remains the best hope for recovery. Or an illness of high risk the important genetic findings that have enhanced our understanding of genetics are discussed in this article. Novel treatments and outcome prediction.

Background: Leukaemia accounts for 8% of all cancer cases and affects people of all ages, with variable prevalence and incidence rates throughout Iran and around the world, resulting in a high death toll and high costs. For the purposes of diagnosis and therapy This research looked at the epidemiology and morphology of blood. Between 2003 and 2008.

Materials and Procedures: This cross-sectional investigation was conducted using re A 6 year review of the cancer registry center report of the Iranian health deputy (2003–2008). Join point was used to perform statistical analysis for incidence time trends and morphological change percentage. Join point regression program was used to do the regression analysis.

Results: During the years examined, a total of were 18,353 malignancies of the hematopoietic and reticuloendothelial systems documented.